Tag Archives: Struggle

Novartis’ SMA gene therapy Zolgensma could struggle to hit blockbuster territory: report

Despite an ongoing soap opera surrounding Zolgensma, Novartis’ gene therapy for spinal muscular atrophy (SMA), Wall Street analysts are optimistic about the product overall, with some estimating peak sales north of $ 2 billion a year. JPMorgan analysts surveyed 26 physicians who treat SMA and came to a vastly different conclusion: Concerns about the efficacy of… Read More »